The role of National Institutes of Health category IV prostatitis in accurately staging the newly diagnosed prostate cancer

Aglamis E., Tasdemir C., Ceylan C.

IRISH JOURNAL OF MEDICAL SCIENCE, cilt.182, sa.3, ss.463-467, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 182 Sayı: 3
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s11845-013-0914-1
  • Dergi Adı: IRISH JOURNAL OF MEDICAL SCIENCE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.463-467
  • İnönü Üniversitesi Adresli: Evet

Özet

It has been known that the National Institutes of Health category IV (NIH-IV) prostatitis increases the serum total prostate-specific antigen (tPSA) in patients with benign prostatic hyperplasia. However, the effect of NIH-IV prostatitis on tPSA levels, which are used for staging prostate cancer (PCa) in patients with PCa, has not been previously investigated.